Stay tuned! Registration opens soon!

Hybrid Access | TBD CE/CME Credits & MOC Points

The Northwell Health Second Annual Liver Cancer Symposium held in Garden City will address the ongoing public health crisis of liver cancer, a disease with one of the lowest survival rates. As research advances, it is crucial for physicians and advanced clinical providers to stay informed on emerging treatments, including new medications and the role of molecular biology and genetic testing in personalizing therapy. This session will provide essential updates on the latest diagnostic and treatment methodologies, equipping attendees with the knowledge needed to optimize patient care and improve survival outcomes.

Conference Agenda
Friday, October 17, 2025

7:00 AM
Coffee and Exhibits

7:30 AM
Program Chair Welcome

8:10 AM – Session 1: Management of Cholangiocarcinoma
This session will cover surgical and transplant considerations, systemic therapies, and the role of interventional radiology and GI diagnostics in optimizing patient outcomes.

9:00 AM
Breakfast and Exhibits      

9:15 AM
Non-CME Breakfast

10:00 AM – Session 2: Hepatology, Fatty Liver Disease, and Liver Cancer
Discussions will focus on the evolving relationship between fatty liver disease and liver cancer, including pharmacologic treatments, endobariatric approaches, and cancer risk assessment.

11:05 AM
Break and Exhibits    

11:15 AM – Session 3: Colon Cancer Liver Metastases
Attendees will gain insights into hepatic artery infusion (HAI), transplant strategies, and multidisciplinary approaches integrating systemic and locoregional therapies

12:10 PM
Lunch and Exhibits      

12:25 PM
Non-CME Lunch    

1:10 PM – Session 4: Keynote – AI in Oncology
Exploring the role of artificial intelligence in oncology, clinical decision-making, and liver cancer treatment. 

1:50 PM – Session 5: Neuroendocrine Tumors
This session will examine the complexities of managing neuroendocrine tumors involving the liver, including nuclear medicine advances such as Lutathera and expert case reviews.

2:30 PM
Break and Exhibits

2:40 PM – Session 6: Liver Cancer, Genomic Testing, and Primary Care
Topics include strategies for early detection in primary care, genomic testing for liver cancer risk, and best practices for evaluating benign liver lesions.

3:20 PM – Session 7: Management of Hepatocellular Carcinoma
Case-based discussion on HCC management, covering systemic and locoregional therapies, transplant eligibility, and complex cases involving vascular invasion.

3:50 PM
ADJOURN

Agenda Subject To Change. All times are EST.

• Learning Objectives

  At the conclusion of this conference, participants should be able to:

  • Review and analyze advances in the treatment of liver cancers including newly available clinical trials.

  • Identify specific clinical trials available to liver cancer patients at different stages of their disease process.

  • Describe specific molecular or genetic mutations found in liver cancers that would indicate use of a specific medication to treat the disease.

• Accreditation Information | TBD

  In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  Nurses (ANCC) Credit Designation

  Amedco LLC designates this activity for a maximum of 5.50 ANCC contact hours.

  Physicians (ACCME) Credit Designation

  Amedco LLC designates this live activity for a maximum of 5.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

  Amedco LLC designates this activity for a maximum of 5.50 knowledge-based CPE contact hours.

  NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

  American Board of Internal Medicine (ABIM) MOC Credit

  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.40 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.

• What to Expect | In-Person Learners

  • Free registration for all healthcare providers

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies

  • Real-time discussion and debate

  • Networking with peers, colleagues, and medical professionals

  • Access to the latest industry information and resources

  • Catered meals through-out the program